Sensorion Announces New Positive Secondary Efficacy Endpoints Data From SENS-401 Phase 2a Clinical Trial For The Preservation Of Residual Hearing Loss
This part is Partnership Content providedThe content material on this part is provided by Business Wire for the needs of ...


